The Board of Directors of Hubei Jumpcan Pharmaceutical Co., Ltd. has authorized a buyback plan on July 3, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.63 CNY | -1.49% | +1.19% | +32.45% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.45% | 5.31B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.